The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / What Does Stage 2 Meaningful Use Mean for Your Rheumatology Practice?

What Does Stage 2 Meaningful Use Mean for Your Rheumatology Practice?

November 1, 2012 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The Centers for Medicare and Medicaid Services (CMS) recently published the final rule for the next stage of the Meaningful Use Incentive Program. Stage 1 focused on data capturing and sharing. Stage 2, which has been delayed until 2014, will focus on using data collected for more advanced clinical processes.

You Might Also Like
  • Meaningful Use and Patient Engagement – Supporting eHealth Literacy
  • Stage 2 of the EHR Incentive Program
  • Rheumatology Informatics System for Effectiveness Registry Can Help Physicians Improve Practice Performance
Explore This Issue
November 2012
Also By This Author
  • Avoid the 2015 PQRS Negative Payment Adjustment

Stage 1 Revisited

As authorized by the 2009 American Recovery and Reinvestment Act, CMS is providing reimbursement incentives to providers who can demonstrate ‘meaningful use’ of electronic health record (EHR) systems. Like their colleagues throughout medicine, many rheumatology providers were practicing in settings that use paper medical records. Through the CMS EHR Incentive Program, the government is incentivizing providers and hospitals to:

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
  • Adopt EHRs;
  • Implement the systems locally in ways that fully realize the potential of electronic systems; and
  • Use the EHRs to exchange data.

The program is one component of the broader Health Information Technology for Economic and Clinical Health Act (HITECH) and raises the potential for greater efficiency, improved quality, and effectively coordinated care. HITECH’s reach includes the development of a framework and infrastructure to support health information technology adoption and implementation, health information exchange infrastructure, HIT workforce training, and health information and communication systems research and development.

A timeline for incentives based on the year you begin attestation is outlined in Table 1

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

click for large version
Table 1: Meaningful Use Incentives

The Stage 2 Rule Has Been Released—How It Affects You

The basic framework for meaningful use includes requirements to meet all core measures in addition to selecting from a number of menu measures, as well as to report on clinical quality measures. In Stage 1, providers reported on 15 core measures and five of 10 menu measures. In Stage 2, providers will need to report on 17 core objectives and select three of six menu set objectives. However, there are increasing thresholds and requirements in Stage 2, and many of the measures now have multiple parts.

Changes in Action

Stage 2 of meaningful use raises the bar on many of the requirements of Stage 1, in addition to introducing some new focus areas. For example, there is a stronger emphasis on the use of electronic messaging in order to communicate with patients about relevant health information. In addition, patients will need to have the ability to view, download, and transmit their health information to their provider with at least 5% of all unique patients actually accessing their information. Also, there will be a focus on summary-of-care records being made available for transitions of care and referrals. Another major area will be implementing clinical decision support interventions on high-priority health conditions, which will also tie in with the updated clinical quality measures.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 | Single Page

Filed Under: Electronic Health Records, From the College, Information Technology, Legislation & Advocacy, Practice Management, Quality Assurance/Improvement, Technology Tagged With: AC&R, American College of Rheumatology, CMS, electronic health record, Meaningful use, Medicare, Practice Management, Research, rheumatologist, TechnologyIssue: November 2012

You Might Also Like:
  • Meaningful Use and Patient Engagement – Supporting eHealth Literacy
  • Stage 2 of the EHR Incentive Program
  • Rheumatology Informatics System for Effectiveness Registry Can Help Physicians Improve Practice Performance
  • Planning is Key to Meaningful Use

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)